Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Expression pattern of apoptosis-inducing factor in the kidneys of streptozotocin-induced diabetic rats (CROSBI ID 286187)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Kostic, Sandra ; Hauke, Tim ; Ghahramani, Nasrollah ; Filipovic, Natalija ; Vukojevic, Katarina Expression pattern of apoptosis-inducing factor in the kidneys of streptozotocin-induced diabetic rats // Acta histochemica, 122 (2020), 8; 151655, 8. doi: 10.1016/j.acthis.2020.151655

Podaci o odgovornosti

Kostic, Sandra ; Hauke, Tim ; Ghahramani, Nasrollah ; Filipovic, Natalija ; Vukojevic, Katarina

engleski

Expression pattern of apoptosis-inducing factor in the kidneys of streptozotocin-induced diabetic rats

Background It is believed that tubulo-interstitial fibrosis and atrophy in diabetic patients are directly associated with the progression of chronic kidney disease, CKD. AIF is one of the crucial factors responsible for mitochondrial apoptosis, however, it can also promote cell survival independently from its role in apoptosis, and therefore can be potentially used as a tool in prevention of the onset of CKD in diabetic patients. Our aim was to investigate the significance of AIF expression in the development of CKD by observing the expression of AIF in 2 weeks’ and 2 months’ kidneys of diabetic rats compared to their controls. Methods Male Sprague–Dawley rats were treated with 55 mg/kg streptozotocin (model of type 1 diabetes mellitus ; DM group) or citrate buffer (control). After 2 weeks and 2 months kidney samples were collected and analysed in different renal areas. Results Characteristic morphologic changes were found between the 2 months’ control and 2 months’ diabetic groups. Those changes, including fibrosis and possible replacement of podocytes with connective tissue were mainly present in the glomeruli. AIF expression was seen in the both cortex, and in the collecting ducts of the medulla. Strong intensity of AIF expression was seen in proximal and distal convoluted tubules in both diabetic groups. In the control groups the glomeruli showed no AIF staining but moderate staining was seen in both diabetic groups. Overall, the percentage of AIF positive cells in the glomeruli was the lowest. The greatest rise in cell positivity was displayed from the 2 weeks’ control group to 2 weeks’ diabetes group (38 %) in glomeruli. The cell positivity of the 2 weeks’ diabetic group is significantly reduced to 18 % in the 2 months’ diabetic group in glomeruli. A similar pattern was seen in the proximal tubular cells (92 % positivity 2 weeks diabetic groups ; 89 % positivity 2 months diabetic groups), as well as in the distal tubules. The highest percentage of AIF positive cells was seen in the collecting ducts, more than 80 % in all groups. Conclusions Our study provides insight into AIF expression pattern during short term diabetes model, confirming possible dual role of AIF, not only in apoptosis but also in cell function and homeostasis, and proving AIF as potential therapeutic target and marker of advancement of CKD.

AIF ; Diabetic nephropathy ; Renal fibrosis

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

122 (8)

2020.

151655

8

objavljeno

0065-1281

1618-0372

10.1016/j.acthis.2020.151655

Povezanost rada

Temeljne medicinske znanosti

Poveznice
Indeksiranost